PP
ALNY icon

Prudential plc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Prudential plc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Hold
7,696
– – 0.01% 381
2026
Q1 		$2.55M Sell
7,696
-133
-2% -$45.3K 0.01% 363
2025
Q4 		$3.11M Buy
7,829
+133
+2% +$58.9K 0.02% 334
2025
Q3 		$3.51M Buy
7,696
+3,584
+87% +$1.46M 0.03% 327
2025
Q2 		$1.34M Buy
4,112
+2,065
+101% +$571K 0.01% 458
2025
Q1 		$553K Sell
2,047
-2,233
-52% -$574K ﹤0.01% 573
2024
Q4 		$1.01M Buy
4,280
+1,264
+42% +$332K 0.01% 510
2024
Q3 		$829K Buy
3,016
+143
+5% +$37.2K ﹤0.01% 549
2024
Q2 		$698K Hold
2,873
– – ﹤0.01% 539
2024
Q1 		$429K Sell
2,873
-1,994
-41% -$333K ﹤0.01% 621
2023
Q4 		$932K Sell
4,867
-11
-0.2% -$1.87K 0.01% 601
2023
Q3 		$864K Sell
4,878
-761
-13% -$145K 0.01% 570
2023
Q2 		$1.07M Sell
5,639
-81
-1% -$16.1K 0.01% 552
2023
Q1 		$1.15M Buy
5,720
+6
+0.1% +$1.26K 0.01% 513
2022
Q4 		$1.36M Buy
5,714
+3,617
+172% +$771K 0.02% 462
2022
Q3 		$420K Buy
2,097
+316
+18% +$60.3K 0.01% 628
2022
Q2 		$260K Hold
1,781
– – ﹤0.01% 734
2022
Q1 		$291K Buy
+1,781
New +$271K ﹤0.01% 736

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential plc's ALNY Position: Q2 2026 in Review

Prudential plc held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 7,696 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #381.

Prudential plc first reported a position in ALNY in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.51M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Prudential plc held 7,696 shares of Alnylam Pharmaceuticals worth $2.32M as of Q2 2026.
  • Prudential plc left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Prudential plc's portfolio in Q2 2026, its #381 holding.
  • Prudential plc first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Prudential plc's Alnylam Pharmaceuticals position peaked at $3.51M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.